Evidence map›Paper›PMID 36183140›Full record

ArticleImplementation science : IS2022

Randomized controlled trials in de-implementation research: a systematic scoping review.

Aleksi J Raudasoja, Petra Falkenbach, Robin W M Vernooij, Jussi M J Mustonen, Arnav Agarwal, Yoshitaka Aoki, Marco H Blanker, Rufus Cartwright, Herney A Garcia-Perdomo, Tuomas P Kilpeläinen and 9 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in Implementation science : IS, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 13 institutions in 6 countries.

Aleksi J RaudasojaFaculty of Medicine, University of Helsinki, Helsinki, Finland. raudasoja.aleksi@gmail.com.ORCID 0000-0002-9117-8861
Petra FalkenbachFinnish Coordinating Center for Health Technology Assessment, Oulu University Hospital, Oulu, Finland.
Robin W M VernooijDepartment of Nephrology and Hypertension, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.ORCID 0000-0001-5734-4566
Jussi M J MustonenOccupational Health Helsinki, Helsinki, Finland.
Arnav AgarwalDivision of General Internal Medicine, Department of Medicine and Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, ON, Canada.
Yoshitaka AokiDepartment of Urology, University of Fukui Faculty of Medical Sciences, Fukui, Japan.ORCID 0000-0002-4365-443X
Marco H BlankerDepartment of General Practice and Elderly Care Medicine, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.ORCID 0000-0002-1086-8730
Rufus CartwrightDepartment of Gynaecology, Chelsea & Westminster NHS Foundation Trust, London, UK.ORCID 0000-0001-5501-319X
Herney A Garcia-PerdomoDivision of Urology/Uro-oncology, Department of Surgery, School of Medicine, Universidad del Valle, Cali, Colombia.
Tuomas P KilpeläinenDepartment of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0002-7697-0148
Olli LainialaDepartment of Radiology, Tampere University Hospital and Faculty of Medicine and Health Technologies, Tampere University, Tampere, Finland.ORCID 0000-0002-5665-229X
Tiina LambergFinnish Medical Society Duodecim, Helsinki, Finland.
Olli P O NevalainenFaculty of Medicine, University of Helsinki, Helsinki, Finland.
Eero RaittioOral Health Care, Tampere, Finland.ORCID 0000-0002-9258-9355
Patrick O RichardDivision of Urology, Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Canada.
Philippe D VioletteDepartments of Surgery and Health Research Methods Evidence and Impact, McMaster University, Hamilton, Canada.ORCID 0000-0002-6116-5496
Jorma KomulainenFinnish Medical Society Duodecim, Helsinki, Finland.ORCID 0000-0001-8884-2867
Raija SipiläFinnish Medical Society Duodecim, Helsinki, Finland.ORCID 0000-0002-5071-8681
Kari A O TikkinenDepartment of Urology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
University of Helsinki · FIFinnish Medical Society Duodecim · FIImpact · CACentre Hospitalier Universitaire de Sherbrooke · CAChelsea and Westminster Hospital NHS Foundation Trust · GBFinnish Institute of Occupational Health · FIOulu University Hospital · FITampere University Hospital · FIUniversidad del Valle · COUniversity Medical Center Groningen · NLUniversity of Eastern Finland · FIUniversity of Fukui · JPUtrecht University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHealthcare costs are rising, and a substantial proportion of medical care is of little value. De-implementation of low-value practices is important for improving overall health outcomes and reducing costs. We aimed to identify and synthesize randomized controlled trials (RCTs) on de-implementation interventions and to provide guidance to improve future research.

methodsMEDLINE and Scopus up to May 24, 2021, for individual and cluster RCTs comparing de-implementation interventions to usual care, another intervention, or placebo. We applied independent duplicate assessment of eligibility, study characteristics, outcomes, intervention categories, implementation theories, and risk of bias.

resultsOf the 227 eligible trials, 145 (64%) were cluster randomized trials (median 24 clusters; median follow-up time 305 days), and 82 (36%) were individually randomized trials (median follow-up time 274 days). Of the trials, 118 (52%) were published after 2010, 149 (66%) were conducted in a primary care setting, 163 (72%) aimed to reduce the use of drug treatment, 194 (85%) measured the total volume of care, and 64 (28%) low-value care use as outcomes. Of the trials, 48 (21%) described a theoretical basis for the intervention, and 40 (18%) had the study tailored by context-specific factors. Of the de-implementation interventions, 193 (85%) were targeted at physicians, 115 (51%) tested educational sessions, and 152 (67%) multicomponent interventions. Missing data led to high risk of bias in 137 (60%) trials, followed by baseline imbalances in 99 (44%), and deficiencies in allocation concealment in 56 (25%).

conclusionsDe-implementation trials were mainly conducted in primary care and typically aimed to reduce low-value drug treatments. Limitations of current de-implementation research may have led to unreliable effect estimates and decreased clinical applicability of studied de-implementation strategies. We identified potential research gaps, including de-implementation in secondary and tertiary care settings, and interventions targeted at other than physicians. Future trials could be improved by favoring simpler intervention designs, better control of potential confounders, larger number of clusters in cluster trials, considering context-specific factors when planning the intervention (tailoring), and using a theoretical basis in intervention design. REGISTRATION: OSF Open Science Framework hk4b2.

Indexed as

Randomized Controlled Trials as TopicHumansClinical trialsCluster randomized trialDe-implementationLow-value careMethodsOveruseRandomized controlled trialScoping reviewTrial design

Identifiers

PMID36183140
PMCPMC9526943
OpenAlexW4298204163

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.